We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Innovative Smartband Predicts Pending Epileptic Seizures

By HospiMedica International staff writers
Posted on 23 Jan 2019
Print article
Image: The Empatica Embrace epilepsy smartband (Photo courtesy of Empatica).
Image: The Empatica Embrace epilepsy smartband (Photo courtesy of Empatica).
A novel bracelet device detects motion patterns and physiological signals that may be associated with generalized tonic clonic (GTC) epileptic seizures.

The Empatica (Cambridge, MA, USA) Embrace epilepsy smartband measures a range of electrodermal activity (EDA) data in order to quantify physiological changes that are related to sympathetic nervous system activity. An on-board algorithm continuously processes sensor data and make a decision about whether the data might indicate a GTC seizure. Embrace then sends a message to the smartphone application, which initiates calls and texts to summon a designated caregiver. The wearable biosensor device also captures, stores, and wirelessly transmits EDA data for future analysis.

In a multi-site clinical study, 135 patients diagnosed with epilepsy underwent continuous monitoring with video electroencephalography (EEG), while simultaneously wearing an Empatica device, resulting in 6,530 hours of data recorded over 272 days, including documentation of 40 GTC seizures; the algorithm detected 100% of the seizures clinically labelled by at least two out of three independent epileptologists, who examined the video-EEG data without seeing any data used by Embrace.

“Medical devices face a huge problem: they're usually too bulky and uncomfortable, and people simply don't want to wear them. Empatica took a different path. We wanted to design the world's first medical device that could win a design award, while being used as a lifesaving product,” said Matteo Lai, CEO and co-founder of Empatica. “Patients actually love Embrace and are proud to wear it. We think this has been one of the keys of its success and an interesting lesson for healthcare. Cutting edge technology and good design need to go together.”

A GTC (commonly known as a grand mal seizure) produces bilateral, convulsive, tonic and clonic muscle contractions. They typically start abruptly with either focal or generalized onset, with tonic contractions usually preceding clonic contractions. After these series of contractions, there is an extended post-ictal state where the person is unresponsive and commonly asleep, with loud snoring. Pronounced confusion is usually present upon awakening.

Related Links:
Empatica

Gold Member
12-Channel ECG
CM1200B
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Surgical Planning Software and Guide
Signature ONE Surgical Planning

Print article

Channels

Critical Care

view channel
Image: Peerbridge Cor is a 3-lead, 2-channel wireless AECG that simplifies the testing and diagnostic process (Photo courtesy of Peerbridge Health)

First-of-its-Kind Trial to Measure Ejection Fraction Severity Directly from AI-Enabled Remote ECG Wearable

Echocardiograms are a standard diagnostic tool to measure ejection fraction but require a clinical setting for administration. This can pose challenges such as scheduling delays, staffing shortages, accessibility... Read more

Surgical Techniques

view channel
Image: Fixation screws for ligament to bone repair (Photo courtesy of 4D Medicine)

Novel Biomaterial Platform Opens Up New Possibilities for Implants and Devices

Resorbable biomaterials, crucial for implantable medical devices, have seen little innovation over decades. Materials like Polylactic Acid (PLA), Polycaprolactone (PCL), and Poly Lactic-co-Glycolic Acid... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.